University of Arkansas, Department of Psychology, Fayetteville, AR 72701, United States.
Addict Behav. 2010 Jun;35(6):625-7. doi: 10.1016/j.addbeh.2010.01.010. Epub 2010 Jan 29.
Evidence documents elevated rates of various types of drug use among people with posttraumatic stress disorder (PTSD). However, relatively little research has specifically examined crystal methamphetamine (CM) use among individuals with PTSD. The present study examined the relation between PTSD diagnostic status, PTSD symptom severity within symptom type clusters, and CM use histories among traumatic event-exposed individuals with versus without PTSD. Consistent with expectations, individuals with PTSD were significantly more likely to report CM use than trauma-exposed individuals without PTSD. Additionally, CM users with PTSD reported a longer duration of CM use than trauma-exposed CM users without PTSD. Finally, PTSD avoidance and hyperarousal symptoms, but not re-experiencing, were related to CM use. The potential clinical and research implications of the findings are discussed.
证据表明，创伤后应激障碍（PTSD）患者的各种药物使用频率较高。然而，专门研究 PTSD 患者使用冰毒（CM）的研究相对较少。本研究探讨了 PTSD 诊断状态、症状类型簇内 PTSD 症状严重程度与 PTSD 患者和无 PTSD 的创伤暴露个体 CM 使用史之间的关系。与预期一致，PTSD 患者报告 CM 使用的可能性显著高于无 PTSD 的创伤暴露个体。此外，PTSD 患者的 CM 使用时间长于无 PTSD 的创伤暴露 CM 使用者。最后，回避和警觉症状与 CM 使用有关，而不是再体验症状。讨论了这些发现的潜在临床和研究意义。
